- Home
- RAND vs VTGN Comparison
RAND vs VTGN Comparison
Compare RAND & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAND
- VTGN
- Stock Information
- Founded
- RAND 1969
- VTGN 1998
- Country
- RAND United States
- VTGN United States
- Employees
- RAND N/A
- VTGN N/A
- Industry
- RAND Finance: Consumer Services
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- RAND Finance
- VTGN Health Care
- Exchange
- RAND Nasdaq
- VTGN Nasdaq
- Market Cap
- RAND 54.4M
- VTGN 87.2M
- IPO Year
- RAND N/A
- VTGN N/A
- Fundamental
- Price
- RAND $16.13
- VTGN $3.34
- Analyst Decision
- RAND
- VTGN
- Analyst Count
- RAND 0
- VTGN 0
- Target Price
- RAND N/A
- VTGN N/A
- AVG Volume (30 Days)
- RAND 5.0K
- VTGN 598.9K
- Earning Date
- RAND 08-04-2025
- VTGN 08-07-2025
- Dividend Yield
- RAND 10.35%
- VTGN N/A
- EPS Growth
- RAND N/A
- VTGN N/A
- EPS
- RAND N/A
- VTGN N/A
- Revenue
- RAND $7,966,118.00
- VTGN $646,000.00
- Revenue This Year
- RAND N/A
- VTGN $46.91
- Revenue Next Year
- RAND N/A
- VTGN $504.34
- P/E Ratio
- RAND N/A
- VTGN N/A
- Revenue Growth
- RAND 1.16
- VTGN N/A
- 52 Week Low
- RAND $13.82
- VTGN $1.90
- 52 Week High
- RAND $31.89
- VTGN $3.59
- Technical
- Relative Strength Index (RSI)
- RAND 46.94
- VTGN 62.92
- Support Level
- RAND $15.17
- VTGN $3.01
- Resistance Level
- RAND $16.20
- VTGN $3.26
- Average True Range (ATR)
- RAND 0.91
- VTGN 0.21
- MACD
- RAND 0.06
- VTGN -0.00
- Stochastic Oscillator
- RAND 71.52
- VTGN 68.42
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.